Back

Angiotensin-converting enzyme inhibitors show an edge over angiotensin II receptor blockers in cardiovascular outcomes

EHJ - Open

28 July 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HYPERTENSION

Contributors

Carl J Lavie
Carl J Lavie

Author

Maciej Banach
Maciej Banach

Author

Medical University of Lodz Lodz , Poland

Magnus Bäck
Magnus Bäck

Author

You may be interested in
thumbnail
Congress Presentation
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk
23 May 2023
thumbnail
Congress Presentation
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure
27 August 2023
thumbnail
Congress Presentation
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target mendelian randomisation study
1 September 2025
thumbnail
Congress Presentation
Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources